Wockhardt is a global, pharmaceutical and biotechnology company , leveraging two powerful trends impacting the world of medicine - globalisation and biotechnology.
Wockhardt today, is distinguished by a strong and growing presence in the world’s leading markets, with more than 65% of its revenue coming from Europe and the United States. Wockhardt’s market presence covers formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs).